Status:
COMPLETED
A Study on Vonoprazan in the Real-world Clinical Practice in China
Lead Sponsor:
Takeda
Conditions:
Esophagitis Peptic
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate the safety of Vonoprazan by assessing all adverse events (AEs), serious adverse events (SAEs), and adverse drug reactions (ADRs) in routine clinical settings i...
Detailed Description
This is a prospective, non-interventional study in Chinese participants with RE who are receiving or will receive the standard treatment of vonoprazan. This study will assess the safety and effectiven...
Eligibility Criteria
Inclusion
- Must be undergoing treatment with Vonoprazan.
- Must be at least 18 years old.
- Provide signed informed consent indicating that they (or a legally acceptable representative) have been informed of all pertinent aspects of the study and are willing to participate.
Exclusion
- Are currently enrolled in or plan to participate in any other clinical trials (that is interventional study).
- Are contraindicated for Vonoprazan according to Product Package Insert.
- With a known hepatic function impairment, including jaundice.
Key Trial Info
Start Date :
December 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 27 2023
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04501627
Start Date
December 24 2020
End Date
June 27 2023
Last Update
October 25 2023
Active Locations (40)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Hospital
Beijing, Beijing Municipality, China, 000000
2
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730
3
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, China, 102218
4
Yongchuan Hospital of Chongqing Medical University
Yongchuan, Chongqing Municipality, China, 402160